171 related articles for article (PubMed ID: 20843707)
1. Effective enrichment of prostate cancer stem cells from spheres in a suspension culture system.
Fan X; Liu S; Su F; Pan Q; Lin T
Urol Oncol; 2012; 30(3):314-8. PubMed ID: 20843707
[TBL] [Abstract][Full Text] [Related]
2. A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells.
Zhang Y; Huang Y; Jin Z; Li X; Li B; Xu P; Huang P; Liu C
Tumour Biol; 2016 Sep; 37(9):11973-11981. PubMed ID: 27113741
[TBL] [Abstract][Full Text] [Related]
3. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
Ma L; Lai D; Liu T; Cheng W; Guo L
Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
[TBL] [Abstract][Full Text] [Related]
5. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of retinal cancer stem cell-like properties through long-term serum-free culture from human retinoblastoma.
Ma B; Lei X; Guan Y; Mou LS; Yuan YF; Yue H; Lu Y; Xu GT; Qian J
Oncol Rep; 2011 Jul; 26(1):135-43. PubMed ID: 21573498
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
Kanwal R; Shukla S; Walker E; Gupta S
Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
[TBL] [Abstract][Full Text] [Related]
8. Prospective identification of tumorigenic prostate cancer stem cells.
Collins AT; Berry PA; Hyde C; Stower MJ; Maitland NJ
Cancer Res; 2005 Dec; 65(23):10946-51. PubMed ID: 16322242
[TBL] [Abstract][Full Text] [Related]
9. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
[TBL] [Abstract][Full Text] [Related]
10. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
[TBL] [Abstract][Full Text] [Related]
11. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
Rentala S; Mangamoori LN
J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
[TBL] [Abstract][Full Text] [Related]
12. Isolation and identification of cancer stem-like cells from murine melanoma cell lines.
Dou J; Pan M; Wen P; Li Y; Tang Q; Chu L; Zhao F; Jiang C; Hu W; Hu K; Gu N
Cell Mol Immunol; 2007 Dec; 4(6):467-72. PubMed ID: 18163959
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of the Cancer Stem Phenotype in Sphere Cultures of Prostate Cancer Cell Lines Occurs through Activation of Developmental Pathways Mediated by the Transcriptional Regulator ΔNp63α.
Portillo-Lara R; Alvarez MM
PLoS One; 2015; 10(6):e0130118. PubMed ID: 26110651
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
15. Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446.
Qiu X; Wang Z; Li Y; Miao Y; Ren Y; Luan Y
Cancer Lett; 2012 Oct; 323(2):161-70. PubMed ID: 22521544
[TBL] [Abstract][Full Text] [Related]
16. Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin.
Zhang Y; Jin Z; Zhou H; Ou X; Xu Y; Li H; Liu C; Li B
Cancer Med; 2016 Jun; 5(6):1251-8. PubMed ID: 26899963
[TBL] [Abstract][Full Text] [Related]
17. Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells.
Fedr R; Pernicová Z; Slabáková E; Straková N; Bouchal J; Grepl M; Kozubík A; Souček K
Cytometry A; 2013 May; 83(5):472-82. PubMed ID: 23450810
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells.
Gao W; Wu D; Wang Y; Wang Z; Zou C; Dai Y; Ng CF; Teoh JY; Chan FL
Stem Cell Res Ther; 2018 Sep; 9(1):243. PubMed ID: 30257704
[TBL] [Abstract][Full Text] [Related]
19. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.
Harper LJ; Piper K; Common J; Fortune F; Mackenzie IC
J Oral Pathol Med; 2007 Nov; 36(10):594-603. PubMed ID: 17944752
[TBL] [Abstract][Full Text] [Related]
20. [Isolation and in vitro characterization of CD133(+) side population cells from laryngeal cancer cell line].
Wu CP; Zhou L; Xie M; Tao L; Zhang M; Tian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):752-7. PubMed ID: 22177045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
